Fundraising Fox
Ivan Gergel
InvestorManaging Partner at New Rhein Healthcare Investors, LLC
Pennsylvania
Writes $100K – $5M checks · typically $1.5M
Find your path to Ivan
Sign up to see every warm intro you have to Ivan
- Paths you didn't know you had: your email and LinkedIn already hold routes to Ivan. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Ivan Gergel, MD, MBA, has been Managing Partner and Chief Medical Officer at New Rhein since 2017. A global pharmaceutical R&D executive credited with 14 drug approvals, he previously held senior roles at Nektar Therapeutics, Endo Health Solutions, Forest Laboratories, and SmithKline Beecham, and holds an MD from the University of London and an MBA from Wharton.
Contact· self-published, not guessed
Invests in
Biotech
Deals · 1
Neuraptive TherapeuticsBoard seat
via New Rhein Healthcare Investors, LLC · filed Oct 2022 · $38.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Alveus TherapeuticsAlveus Therapeutics Inc.Butterfly Medical Ltd.Corium International Inc.Corsair PharmaNeurotrope Inc.Realm TherapeuticsTheranica
Investor
Corsair Pharma
Sources: SEC Form D filings · the firm's website · curated public sources.
Colleagues at New Rhein Healthcare Investors, LLC
Frequently asked questions
- Who is Ivan Gergel?
- Ivan Gergel, MD, MBA, has been Managing Partner and Chief Medical Officer at New Rhein since 2017. A global pharmaceutical R&D executive credited with 14 drug approvals, he previously held senior roles at Nektar Therapeutics, Endo Health Solutions, Forest Laboratories, and SmithKline Beecham, and holds an MD from the University of London and an MBA from Wharton.
- Where does Ivan Gergel work?
- Ivan Gergel is Managing Partner at New Rhein Healthcare Investors, LLC.
- What does Ivan Gergel invest in?
- Ivan Gergel invests in Biotech.
- What check size does Ivan Gergel write?
- Ivan Gergel typically writes checks of $100K – $5M.
- What boards does Ivan Gergel sit on?
- Ivan Gergel holds tracked board seats at Alveus Therapeutics, Alveus Therapeutics Inc., Butterfly Medical Ltd., Corium International Inc., Corsair Pharma, Neuraptive Therapeutics, Neurotrope Inc., Realm Therapeutics, Theranica.
- What companies has Ivan Gergel invested in?
- Investments tracked here include Corsair Pharma.
About this profile. Compiled from public sources — New Rhein Healthcare Investors, LLC's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights